|
Market Closed -
Xetra
11:35:57 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 29.80 EUR | -1.32% |
|
-5.70% | - |
| 08-03 | Indivior Pharmaceuticals, Inc. Enters into Senior Secured Term Loan Facility | CI |
| 08-03 | Indivior Pharmaceuticals, Inc. Proposes Special Cash Dividend | CI |
Company Valuation: Indivior Pharmaceuticals, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 2,423 | 2,969 | 2,085 | 1,553 | 4,480 | 4,122 | - | - |
| Change | - | 22.54% | -29.76% | -25.5% | 188.39% | -7.98% | - | - |
| Enterprise Value (EV) 1 | 1,563 | 2,435 | 2,008 | 1,567 | 4,604 | 4,110 | 3,552 | 2,932 |
| Change | - | 55.81% | -17.52% | -21.95% | 193.72% | -10.73% | -13.57% | -17.47% |
| P/E | 12.8x | -57.2x | 1,527x | -34.5x | 21.9x | 9.39x | 8.51x | 7.78x |
| PBR | - | 59.3x | - | -8.02x | -45.8x | - | - | - |
| PEG | - | 0x | -15x | 0x | -0x | 0x | 0.8x | 0.83x |
| Capitalization / Revenue | 3.06x | 3.29x | 1.91x | 1.31x | 3.62x | 3.09x | 2.95x | 2.77x |
| EV / Revenue | 1.98x | 2.7x | 1.84x | 1.32x | 3.72x | 3.09x | 2.54x | 1.97x |
| EV / EBITDA | 7.74x | 10.8x | 6.97x | 4.64x | 10.8x | 5.64x | 4.49x | 3.41x |
| EV / EBIT | 8.36x | 11.5x | 7.47x | 5.02x | 11.1x | 5.97x | 4.82x | 3.68x |
| EV / FCF | 4.61x | -10.7x | -4.86x | -196x | -49.5x | 8.07x | 6.53x | 4.74x |
| FCF Yield | 21.7% | -9.32% | -20.6% | -0.51% | -2.02% | 12.4% | 15.3% | 21.1% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 1.35 | -0.38 | 0.01 | -0.36 | 1.64 | 3.72 | 4.105 | 4.49 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 791 | 901 | 1,093 | 1,188 | 1,239 | 1,332 | 1,400 | 1,489 |
| EBITDA 1 | 202 | 225 | 288 | 338 | 428 | 728.4 | 790.8 | 859.6 |
| EBIT 1 | 187 | 212 | 269 | 312 | 415 | 688.8 | 737.7 | 795.7 |
| Net income 1 | 205 | -53 | 2 | -48 | 210 | 474.3 | 530 | 582.9 |
| Net Debt 1 | -860 | -534 | -77 | 14 | 124 | -12.5 | -570 | -1,191 |
| Reference price 2 | 17.25 | 21.75 | 15.27 | 12.43 | 35.88 | 34.93 | 34.93 | 34.93 |
| Nbr of stocks (in thousands) | 140,437 | 136,489 | 136,551 | 124,970 | 124,854 | 118,014 | - | - |
| Announcement Date | 2/16/22 | 2/16/23 | 2/22/24 | 2/20/25 | 2/26/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 33.44x | 12.14x | 24.6x | 0.59% | 1,047B | |
| 29.82x | - | - | 2% | 646B | |
| 32.61x | 7.57x | 15.74x | 2.68% | 451B | |
| 19.99x | 4.75x | 11.76x | 2.79% | 355B | |
| 21.76x | 5.62x | 13.93x | 2.85% | 291B | |
| 20.88x | 4.29x | 12.24x | 2.06% | 252B | |
| 27.35x | 7.07x | 12.56x | 2.33% | 234B | |
| 13.25x | 4.77x | 9.95x | 3.83% | 203B | |
| -44.51x | 6.43x | 25.11x | 2.26% | 181B | |
| Average | 17.17x | 6.58x | 15.74x | 2.38% | 406.59B | |
| Weighted average by Cap. | 24.24x | 8.07x | 17.81x | 1.97% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- INDV Stock
- E7P Stock
- Valuation Indivior Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
